🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Roivant Sciences Ltd.

ROIV Healthcare
$40.18 +$0.68 (1.72%)
Market Cap: $29.02 B
Gurus Holding
7
Popularity Rank
#1189
% of Shares Held
3.28%
Net Activity (Q2 2026)
+$178.08 M

Guru Ownership Trend

Guru Analysis for Roivant Sciences Ltd. (ROIV)

Roivant Sciences Ltd. (ROIV), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $953.29 M.

Top institutional holders include Cliff Asness and Andreas Halvorsen.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $178.08 M net inflow during the quarter.

Recent activity highlights Steven Cohen who increased their stake by 402.1%. Conversely, Andreas Halvorsen reduced exposure by 5.7%.

Key Holders

Top 5 by Value

$234.03 M
$221.95 M
$158.32 M
$100.12 M
$76.18 M

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$194.12 M
Total Buy Value
New Buys 1
Additions 3
-$16.04 M
Total Sell Value
Reductions 2
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
3
Net Buyers
4

FAQs for Roivant Sciences Ltd. (ROIV)

Major holders include Cliff Asness ($234.03 M), Andreas Halvorsen ($221.95 M), Steven Cohen ($158.32 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 23.73 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $178.08 M, with 4 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited ROIV. The total reported sell value was $16.04 M.

Yes, 1 managers opened new positions in ROIV, and 3 increased their existing holdings. The total reported buy value was $194.12 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.08% Add 11.6% 6,633,560 $234.03 M Q2 2026
0.63% Reduce -5.7% 6,271,467 $221.95 M Q2 2026
0.17% Add 402.1% 4,473,478 $158.32 M Q2 2026
0.88% Add 73.9% 2,829,024 $100.12 M Q2 2026
1.95% 2,152,669 $76.18 M Q2 2026
0.11% Reduce -4.7% 1,349,465 $47.76 M Q2 2026
0.00% New Buy 15,899 $562,680 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form